钛种植体表面改性对巨噬细胞极化影响的研究进展

doi:10.3969/j.issn.1005-4979.2019.04.008

摘要/Abstract

摘要： 种植体植入后不可避免地会引发免疫炎症反应，其发生、发展和转归对骨结合的形成至关重要。巨噬细胞作为固有免疫的重要组成部分，其可塑性使其在免疫调节及组织修复与再生中发挥重要的作用。由于骨免疫学的兴起和生物材料的发展，现在的观点认为可以通过生物材料的修饰达到调节巨噬细胞生物学行为的效果，以利于调节免疫反应，促进骨结合及组织再生。本文主要综述巨噬细胞在种植体植入后免疫反应中的作用及生物材料特性对巨噬细胞生物学行为的影响，进一步理解构建具有免疫调节作用的生物材料的可能性，为种植体的发展及提高种植体的临床应用提供新的方法和设计思路。

关键词: 巨噬细胞极化, 种植体表面改性, 骨免疫学, 组织修复与再生

Abstract: Immuno-inflammatory reaction is inevitable after implantation. Its origin, development and outcome are critical to the osseointegration. Macrophages, as an important part of innate immunity, has high plasticity and play an important role in immune regulation, tissue repair and regeneration. Due to the rise of osteoimmunology and the development of biomaterials, it is now believed that the modification of biomaterials could achieve the purpose of regulating the biological behavior of macrophages, as to facilitate the regulation of immune response and promote osseointegration and tissue regeneration. This article mainly reviews the role of macrophages in the immune response after implantation and the influence of biomaterials characteristics on the biological behavior of macrophages, further understands the possibility of developing the immunoregulatory biological materials, provides new method and design cues for the development of implant and improvement of clinical application.

Key words: macrophage polarization, surface modification of implant, osteoimmunology, tissue repair and regeneration

中图分类号:

R782

李庆帆（综述），王佐林（审校）. 钛种植体表面改性对巨噬细胞极化影响的研究进展[J]. 《口腔颌面外科杂志》, doi: 10.3969/j.issn.1005-4979.2019.04.008.

LI Qing-fan, WANG Zuo-lin. Progresses in the Effect of Titanium Implant Surface Modification on Macrophage Polarization[J]. 《Journal of Oral and Maxillofacial Surgery》, doi: 10.3969/j.issn.1005-4979.2019.04.008.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2019/V29/I4/224

参考文献

[1] Albrektsson T, Br?覽nemark PI, Hansson HA, et al. Osseointegrated titanium implants. Requirements for ensuring a long-lasting, direct bone-to-implant anchorage in man[J]. Acta Orthop Scand, 1981, 52(2):155-170.

[2] Badylak SF, Gilbert TW. Immune response to biologic scaffold materials[J]. Semin Immunol, 2008, 20(2):109-116.

[3] Han HJ, Kim S, Han DH. Multifactorial evaluation of implant failure: a 19-year retrospective study [J]. Int J Oral Maxillofac Implants, 2014, 29(2):303-310.

[4] Brown BN, Badylak SF. Expanded applications, shifting paradigms, and an improved understanding of host-biomaterial interactions[J]. Acta Biomater, 2013, 9(2):4948-4955.

[5] Janeway CA, Medzhitov R. Innate Immune Recognition [J]. Annu Rev Immunol, 2002, 20(1):197-216.

[6] Mills CD, Lenz LL, Ley K. Macrophages at the fork in the road to health or disease[J]. Front Immunol, 2015, 6:59.

[7] Mantovani A, Biswas SK, Galdiero MR, et al. Macrophage plasticity and polarization in tissue repair and remodeling[J]. J Pathol, 2013, 229(2):176-185.

[8] Underwood RA, Usui ML, Zhao G, et al. Quantifying the effect of pore size and surface treatment on epidermal incorporation into percutaneously implanted sphere-templated porous biomaterials in mice[J]. J Biomed Mater Res A, 2011, 98(4):499-508.

[9] Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials[J]. Semin Immunol, 2008, 20(2):86-100.

[10] Omar O, Lenner?覽s M, Svensson S, et al. Integrin and chemokine receptor gene expression in implant-adherent cells during early osseointegration[J]. J Mater Sci Mater Med, 2010, 21(3):969-980.

[11] Rao AJ, Gibon E, Ma T, et al. Revision joint replacement, wear particles, and macrophage polarization[J]. Acta Biomater, 2012, 8(7):2815-2823.

[12] Anderson JM. Inflammatory response to implants [J]. Trans Am Soc Artif Intern Organs, 1988, 34(2):101.

[13] Kajahn J, Franz S, Rueckert E, et al. Artificial extracellular matrices composed of collagen I and high sulfated hyaluronan modulate monocyte to macrophage differentiation under conditions of sterile inflammation [J]. Biomatter, 2012, 2(4):226-236.

[14] Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation[J]. Immunity, 2014, 40(1):91-104.

[15] Davies LC, Jenkins SJ, Allen JE, et al. Tissue-resident macrophages[J]. Nat Immunol, 2013, 14(10):986-995.

[16] Shapouri-Moghaddam A, Mohammadian S, Vazini H, et al. Macrophage plasticity, polarization, and function in health and disease[J]. J Cell Physiol, 2018, 233(9):6425-6440.

[17] Williams DF. On the mechanisms of biocompatibility [J]. Biomaterials, 2008, 29(20):2941-2953.

[18] Ratner BD, Bryant SJ. Biomaterials: where we have been and where we are going [J]. Annu Rev of Biomed Eng, 2004, 6:41-75.

[19] Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity[J]. Nat Rev Immunol, 2011, 11(11):750-761.

[20] Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization[J]. Trends Immunol, 2004, 25(12):677-686.

[21] Sridharan R, Cameron AR, Kelly DJ, et al. Biomaterial based modulation of macrophage polarization: a review and suggested design principles[J]. Mater Today, 2015, 18(6):313-325.

[22] Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization[J]. Trends Immunol, 2004, 25(12):677-686.

[23] Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev Immunol, 2008, 8(12):958-969.

[24] Saccani A, Schioppa T, Porta C, et al. p50 nuclear factor-kappaB overexpression in tumor-associated macrophages inhibits M1 inflammatory responses and antitumor resistance[J]. Cancer Res, 2006, 66(23):11432-11440.

[25] Spiller KL, Nassiri S, Witherel CE, et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds [J]. Biomaterials, 2015, 37:194-207.

[26] Civantos A, Martínez-Campos E, Ramos V, et al. Titanium coatings and surface modifications: toward clinically useful bioactive implants[J]. Acs Biomater Sci Eng, 2017, 3(7):1245-1267.

[27] Thalji G, Cooper LF. Molecular assessment of osseointegration in vitro: A rof current literature [J]. Int J Oral Maxillofac Implants, 2014, 29(2): e171-199.

[28] Lee RSB, Hamlet SM, Ivanovski S. The influence of titanium surface characteristics on macrophage phenotype polarization during osseous healing in type I diabetic rats: a pilot study[J]. Clin Oral Implants Res, 2017, 28(10): e159-e168.

[29] Refai AK, Textor M, Brunette DM, et al. Effect of titanium surface topography on macrophage activation and secretion of proinflammatory cytokines and chemokines[J]. J Biomed Mater Res A, 2004, 70(2):194-205.

[30] Tan KS, Qian L, Rosado R, et al. The role of titanium surface topography on J774A.1 macrophage inflammatory cytokines and nitric oxide production [J]. Biomaterials, 2006, 27(30):5170-5177.

[31] Luu TU, Gott SC, Woo BWK, et al. Micro and nano-patterned topographical cues for regulating macrophage cell shape and phenotype[J]. ACS Appl Mater Interfaces, 2015, 7(51):28665-28672.

[32] Ma QL, Zhao LZ, Liu RR, et al. Improved implant osseointegration of a nanostructured titanium surface via mediation of macrophage polarization [J]. Biomaterials, 2014, 35(37):9853-9867.

[33] Mendon?觭a G, Mendon?觭a DB, Arag?觔o FJ, et al. Advancing dental implant surface technology-From micron- to nanotopography[J]. Biomaterials, 2008, 29(28):3822-3835.

[34] Brodbeck WG, Nakayama Y, Matsuda T, et al. Biomaterial surface chemistry dictates adherent monocyte/macrophage cytokine expression in vitro[J]. Cytokine, 2002, 18(6):311-319.

[35] Hotchkiss KM, Reddy GB, Hyzy SL, et al. Titanium surface characteristics, including topography and wettability, alter macrophage activation[J]. Acta Biomater, 2016, 31:425-434.

[36] Li K, Shen Q, Xie Y, et al. Incorporation of cerium oxide into hydroxyapatite coating regulates osteogenic activity of mesenchymal stem cell and macrophage polarization[J]. J Biomater Appl, 2017, 31(7):1062-1076.

[37] Singh A, Talekar M, Raikar A, et al. Macrophage-targeted delivery systems for nucleic acid therapy of inflammatory diseases[J]. J Control Release. 2014, 190:515-530.

[38] Carvalho V, Castanheira P, Faria TQ, et al. Biological activity of heterologous murine interleukin-10 and preliminary studies on the use of a dextrin nanogel as a delivery system[J]. Inter J Pharm, 2010, 400(1-2):234-242.

[39] Braat H, Peppelenbosch MP, Hommes DW. Interleukin-10-based therapy for inflammatory bowel disease[J]. Expert Opin Biol Ther, 2003,3(5):725-731.

[40] Hachim D, LoPresti ST, Yates CC, et al. Shifts in macrophage phenotype at the biomaterial interface via IL-4 eluting coatings are associated with improved implant integration[J]. Biomaterials, 2017, 112:95-107.

[41] Kumar M, Gupta P, Bhattacharjee S, et al. Immunomodulatory injectable silk hydrogels maintaining functional islets and promoting anti-inflammatory M2 macrophage polarization[J]. Biomaterials, 2018,187:1-17.

[42] Spiller KL, Nassiri S, Witherel CE, et al. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds[J]. Biomaterials, 2015, 37:194-207.

[43] Ong SM, Biswas SK, Wong SC. MicroRNA-mediated immune modulation as a therapeutic strategy in host-implant integration[J]. Adv Drug Deliv Rev, 2015, 88:92-107.

[44] De Miguel MP, Fuentes-Juli?觃n S, Bl?觃zquez-Martínez A, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications [J]. Curr Mol Med, 2012, 12(5):574-591.

[45] Hoogduijn MJ, Popp F, Verbeek R, et al. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy[J]. Int Immunopharmacol, 2010, 10(12):1496-1500.

[46] Chen L, Tredget EE, Wu Y, et al. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing[J]. PLos One, 2008, 3(4):e1886.

[47] Adutler-Lieber S, Ben-Mordechai T, Naftali-Shani N, et al. Human macrophage regulation via interaction with cardiac adipose tissue-derived mesenchymal stromal cells[J]. J Cardiovasc Pharmacol Ther, 2013, 18(1):78-86.

[48] Freytes DO, Kang JW, Marcos-Campos I, et al. Macrophages modulate the viability and growth of human mesenchymal stem cells[J]. J Cell Biochem, 2013, 114(1):220-229.

选择文件类型/文献管理软件名称

选择包含的内容